Effects of GC7101, a Novel Prokinetic Agent on Gastric Motor Function: Ex Vivo Study

Da Hyun Jung; Eun Ju Choi; Han Ho Jeon; Young Ho Lee; Hyojin Park
October 2014
Journal of Neurogastroenterology & Motility;Oct2014, Vol. 20 Issue 4, p469
Academic Journal
Background/Aims: GC7101, an extract of Lonicera Flos, is a novel developing drug for reflux esophagitis and functional dyspepsia. However, the drug's exact pharmacological mechanism of action remains unclear. This study assessed the effects of GC7101 on gastrointestinal (GI) motor function. Methods: We used male guinea pigs to evaluate the effects of GC7101 on GI motility. The contraction of antral circular muscle in the presence of different doses of GC7101 was measured in a tissue bath. The prokinetic effects of GC7101 were tested using the charcoal transit assay from the pylorus to the most distal point of migration of charcoal mixture. To clarify the mechanism of action of GC7101, atropine, dopamine and the selective 5-hydroxytryptamine 4 receptor antagonist, GR113808 were used. Results: The maximal amplitude of circular muscle contraction was induced by 5 mg mL-1 GC7101. The area under the curve of contraction was significantly increased at 5 mg mL-1 GC7101. Addition of 10-6 M atropine, 10-8 M dopa mine or 10-7 M GR 1 13808 to GC7101 5 mg mL-1 decreased the amplitude and area under curve compared to GC7101 5 mg mL-1 alone. GC7101 accelerated GI transit in a dose dependent manner except 100 mg kg-1 . Delayed GI transit caused by atropine, dopamine and GR 113808 was restored by GC7101 50 mg kg-1. Conclusions: GC7101, an extract of Lonicera Flos, exerts a gastric prokinetic effect in guinea pig through cholinergic, antidopaminergic and serotonergic mechanisms. Therefore, GC7101 might be a novel drug for the treatment of functional dyspepsia.


Related Articles

  • Constitutively Active 5-HT Receptors: An Explanation of How 5-HT Antagonists Inhibit Gut Motility in Species Where 5-HT is Not an Enteric Neurotransmitter? Spencer, Nick J. // Frontiers in Cellular Neuroscience;Dec2015, Vol. 9, p1 

    Antagonists of 5-Hydroxytryptamine (5-HT) receptors are well known to inhibit gastrointestinal (GI)-motility and transit in a variety of mammals, including humans. Originally, these observations had been interpreted by many investigators (including us) as evidence that endogenous 5-HT plays a...

  • Role of Serotonin Type-1A/B (Hydroxytryptamine) Receptors in Depression Revisited. Kanade, Prateek; Gupta, Deepali; Radhakrishnan, Mahesh; Prabhakar, Visakh // Systematic Reviews in Pharmacy;Jan-Dec2013, Vol. 4 Issue 1, p7 

    Depression is among the common psychiatric disorders, therefore the common pathways and pathogenesis associated with depression is required to be studied. In few years, role of 5-hydroxytryptamine-1A/B (5-HT1A/B) receptors in depressive disorders have been revealed. Both preclinical and clinical...

  • Serotonin 5-HT receptor antagonists. II. Synthesis and structure-activity relationship of 3-arylsulfonyl-2-methylthiopyrazolo[1,5- a]pyrimidines with substituents containing an amine in the 6-position. Ivachtchenko, A.; Golovina, E.; Kadieva, M.; Kysil, V.; Mitkin, O.; Okun, I. // Pharmaceutical Chemistry Journal;Sep2012, Vol. 46 Issue 6, p337 

    3-(Arylsulfonyl)-2-(methylthio)pyrazolo[1,5- a]pyrimidines containing substituents with an amine in the 6-position were synthesized. Their structure-activity (antagonist) relationship was studied with respect to serotonin 5-HT receptors. It was shown that 2-(methylthio)-3-(phenylsulfonyl)- and...

  • Dolasetron Injection.  // AHFS Consumer Medication Information;Aug2019, p1 

    Dolasetron injection is used to prevent and treat nausea and vomiting that may occur after surgery in adults and children 2 years of age and older. Dolasetron injection should not be used to prevent or treat nausea and vomiting in people receiving cancer chemotherapy medications. Dolasetron is...

  • Multi-modal antidepressant-like action of 6- and 7-chloro-2-aminodihydroquinazolines in the mouse tail suspension test. Iyer, Kavita A.; Alix, Katie; Eltit, Jose M.; Solis, Ernesto; Pan, Xiaolei; Argade, Malaika D.; Khatri, Shailesh; De Felice, Louis J.; Sweet, Douglas H.; Schulte, Marvin K.; Dukat, Małgorzata // Psychopharmacology;Jul2019, Vol. 236 Issue 7, p2093 

    Rationale: 2-Amino-6-chloro-3,4-dihydroquinazoline (e.g., A6CDQ) represents a novel putative antidepressant originally thought to act through a 5-HT3 serotonin receptor antagonist mechanism. Here, we investigated this further by examining a positional isomer of A6CDQ (i.e., A7CDQ). Materials and...

  • The effects of PRX-07034, a novel 5-HT antagonist, on cognitive flexibility and working memory in rats. Mohler, Eric; Baker, Phillip; Gannon, Kimberly; Jones, Simon; Shacham, Sharon; Sweeney, John; Ragozzino, Michael // Psychopharmacology;Apr2012, Vol. 220 Issue 4, p687 

    Rationale: Accumulating evidence indicates that schizophrenia and autism spectrum disorder patients are marked by cognitive deficits in working memory and strategy switching. There is accumulating evidence that 5-hydroxytryptamine (5-HT) receptors may serve as a useful target to improve...

  • Individual differences in the improvement of cocaine-induced place preference response by the 5-HT receptor antagonist SB242084 in rats. Capriles, Nancy; Watson, Stanley; Akil, Huda // Psychopharmacology;Apr2012, Vol. 220 Issue 4, p731 

    Rationale and objectives: The 5-HT and 5-HT receptors have been shown to be differentially involved in modulating cocaine-induced behaviors. In this study we investigated the effects of the 5-HT antagonist MDL100907 (0.3 mg/kg, i.p.) and the 5-HT antagonist SB242084 (0.5 mg/kg, i.p.) on...

  • Molecular signaling of 5-HT1A and presence of serotonergic cells in the fetal cerebral cortex. de Oca, Alfonso Boyzo Montes; Gutiérrez, Gabriel Manjarrez; Rodríguez, Jorge Hernández // World Journal of Neuroscience;May2013, Vol. 3 Issue 2, p76 

    Early appearance of the serotonergic system in the fetal brain and the various effects of serotonin (5-HT) on brain morphogenesis, have given support to a neurotrophic role of serotonin. This function of serotonin is accomplished through a system of serotonin nerve terminals in the target...

  • Serotonin 2A receptor agonist binding in the human brain with [11C]Cimbi-36. Ettrup, Anders; da Cunha-Bang, Sophie; McMahon, Brenda; Lehel, Szabolcs; Dyssegaard, Agnete; Skibsted, Anine W; Jørgensen, Louise M; Hansen, Martin; Baandrup, Anders O; Bache, Søren; Svarer, Claus; Kristensen, Jesper L; Gillings, Nic; Madsen, Jacob; Knudsen, Gitte M // Journal of Cerebral Blood Flow & Metabolism;Jul2014, Vol. 34 Issue 7, p1188 

    [11C]Cimbi-36 was recently developed as a selective serotonin 2A (5-HT2A) receptor agonist radioligand for positron emission tomography (PET) brain imaging. Such an agonist PET radioligand may provide a novel, and more functional, measure of the serotonergic system and agonist binding is more...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics